medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2012, Number 4

<< Back Next >>

Rev Invest Clin 2012; 64 (4)

Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002

Meneses-García A, Ruiz-Godoy LM, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A

Language: Spanish
References: 40
Page: 322-329
PDF size: 261.13 Kb.


ABSTRACT

Introducción. Cancer is one of the main causes of death worldwide. In Mexico it represents the third cause of death. Objective. To know the frequency and distribution of the malignancies diagnosed in Mexico during 10 years. Material and methods. From the data-base of the histopathological register of malignant neoplasms in Mexico, was obtained a descriptive analysis from the period 1993-2002. The variables included were: city and federative entity of residence, age, sex, anatomical region and histopathologic diagnosis. From the 12 more common malignant neoplasms a descriptive demographic analysis was performed adjusted by four regions: Center, North, South and Federal District. Results. A total of 767,464 cases with cancer were reported. In order of frequency were: cervix-uterine cancer, breast cancer, prostate cancer, lymphomas, colorectal cancer, gastric cancer, sarcomas, ovary cancer, lung cancer, leukemias, urinary bladder cancer and uterine body. Seventy-two percent were diagnosed in women and 28% in men, the reason for a ratio W:M of 2.5:1. The states more developed and industrialized, near to United States had the majority of cases from breast, prostate, ovary and lung cancer. Conclusion. There is a distinctive distribution type of malignant tumors in Mexico, according to the region of residence. It absolutely is necessary to developed population based cancer registries. These are the best instruments to better understand the magnitude of cancer, and evaluate incidence, survival and mortality.


REFERENCES

  1. Stevens G, Dias RH, Thomas KJA, Rivera JA, Carvalho N, Barquera S, Hill K, Ezzati M. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med 5(6): e125. Doi:10.1371/journal.pmed.0050125

  2. Instituto Nacional de Estadística, Geografía e Informática. Disponible en: http://cuentame inegi.gob.mx/impresion/poblacion/ esperanza.asp [Citado 2010, 28 sep]

  3. Tapia CR, Medina ME, Sepúlveda J, De la Fuente R, Kumate J. La encuesta nacional de adicciones en México. Sal Pub Mex 1990; 32: 507-22.

  4. Secretaría de Salud (Mex). CONADIC. INPRF. INEGI. Encuesta Nacional de Adicciones; 2002.

  5. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología; 1998.

  6. Shamah-Levy T, Cuevas-Nasu L, Mundo-Rosas V, Morales- Ruán C, Cervantes-Turrubiates L, Villalpando-Hernández S. Health and nutrition status of older adults in Mexico: results of a national probabilistic survey. Sal Pub Mex 2008; 50: 383-9.

  7. Murray JLCh, Dias HR, Kulkarni CS, Lozano R, Stevens AG, Ezzati M. Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care 2008; 31: 451-8.

  8. Martínez-Palomino G, Vallejo M, García-Moreno J, López-Pérez M, Díaz-Granados R, Badillo-Castillo MO, Garza-Rodarte A. Comparison of traditional cardiovascular risk factors frequency among women of different education levels. Arch Cardiol Mex 2008; 78: 285-92.

  9. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.

  10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr [Accessed on 08/11/2011].

  11. Organización Panamericana de la Salud. Oficina sanitaria panamericana, Oficina regional de la OMS. Clasificación internacional de enfermedades para oncología. Washington, EUA; 2008.

  12. Instituto Nacional de Estadística, Geografía e Informática (INEGI). Bases de datos sobre mortalidad. México, 2009.

  13. Nuño T, Martínez ME, Harris R, García F. A Promotora-administered group education intervention to promote breast and cervical cancer screening in a rural community along the U.S.- Mexico border: a randomized controlled trial. Cancer Causes Control 2011; 22: 367-74.

  14. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 1993.

  15. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 1993-1994.

  16. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 1995.

  17. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 1996.

  18. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 1997.

  19. Compendio del Registro Histopatológico de las Neoplasias Malignas en México. Secretaría de Salud. Dirección General de Epidemiología, 2003.

  20. Gobierno de la República de México 2007. Plan Nacional de Desarrollo 2007-2012, México. México: Gobierno Federal; 2007.

  21. Bosetti C, Rodríguez T, Chatenoud L, Bertuccio P, Levi F, Negri E, La Vecchia C. Trends in cancer mortality in Mexico, 1981-2007. Eur J Cancer Prev 2011; 20: 355-63.

  22. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9.

  23. Rizo-Ríos P, Sierra-Colindres MI, Vázquez-Piñón G, Cano- Guadiana M, Meneses-García A, Mohar A. Registro Hospitalario de Cáncer: Compendio de Cáncer 2000–2004. México: Instituto Nacional de Cancerología; 2007.

  24. Knault FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Cáncer de mama en México: una prioridad apremiante. Sal Pub Mex 2009; 51 (Suppl. 2): S335-S344.

  25. Palacio-Mejía LS, Rangel-Gómez G, Hernández-Ávila M, Lazcano- Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Sal Pub Mex 2003; 45 (Suppl. 3): S315-S325.

  26. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011 [Epub ahead of print].

  27. Mohar A, Bargalló E, Ramírez T, Lara F, Beltrán-Ortega A. Recursos disponibles para el tratamiento del cáncer de mama en México. Sal Pub Mex 2009; 51 (Suppl. 2): S263-S269.

  28. Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D, Blake- Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 2011; 117(16): 3658-69. Doi: 10.1002/ cncr.25961

  29. Brandan ME, Villaseñor Y. Detección del cáncer de mama: Estado de la mamografía en México. Rev INCan Mex 2006; 1: 147-62.

  30. Edefonti V, Decarli A, La Vecchia C, Bosetti C, Randi G, Franceschi S, et al. Nutrient dietary patterns and the risk of breast and ovarian cancers. Int J Cancer 2008; 122: 609-13.

  31. Mousavi SM, Fallah M, Sundquist K, Hemminki K. Age and time dependent changes in cancer incidence among immigrants to Sweden: Colorectal, lung, breast and prostate cancers. Int J Cancer 2011. Doi: 10.1002/ijc.27334.

  32. Weisenburger DD. Epidemiology of non-Hodgkin’s lymphoma: Recent findings regarding an emerging epidemic. Ann Oncol 1994; 5: 19-24.

  33. Meneses G. Diagnóstico diferencial de las lesiones centrofaciales. En: Mosqueda AT. Tópicos selectos de oncología bucal. Clínicas Oncológicas de Iberoamérica. México: PiDesa; 2008, p.162-8.

  34. Quintanilla-Martínez L, Kremer M, Keller G, Nathrath M, Gamboa-Domínguez A, et al. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico. Association with large cell morphology and advanced disease. Am J Pathol 2001; 159: 2095-105.

  35. Abdullaev F, Rivera-Luna R, Roitenburd-Belacortu V, Espinosa- Aguirre J. Pattern of Childhood Cancer Mortality in Mexico. Arch of Med Res 2000; 526-31.

  36. Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 9-18.

  37. Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylory with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71: 297-301.

  38. Bianco E. La epidemia de tabaquismo y su control en Latinoamérica. Sal Pub Mex 2010; 52 (Supl. 2): 94-5.

  39. Ruíz-Godoy L, Rizo-Ríos P, Sánchez-Cervantes F, Osornio- Vargas A, García-Cuellar C, Meneses García A. Mortality due to lung cancer in Mexico. Lung Cancer 2007; 58: 184-90.

  40. Arrieta O, Martínez-Barrera L, Treviño S, Guzmán E, Castillo- González P, Ríos-Trejo MA, et al. Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II-study. J Thorac Oncol 2008; 3: 887-93.




2020     |     www.medigraphic.com